AI in Real-World Evidence: Why the Evidence Base Moved Outside the Trial AI in Real-World Evidence (RWE) has moved from pilot project to operating requirement because regulators, payers, and medical affairs teams now ask questions that randomized controlled trials (RCTs) were never designed to answer. How does a therapy perform in patients over 75 with…

Overview Real-World Data (RWD) to Real-World Evidence (RWE) conversion stands at the center of modern life-sciences decision-making. Randomized controlled trials remain essential for establishing causality under controlled conditions, yet they leave gaps in understanding how treatments perform across diverse patients, care settings, and longer time horizons. RWD, drawn from electronic health records, claims, registries, wearables,…